caffeic acid phenethyl ester has been researched along with bisdemethoxycurcumin in 2 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (bisdemethoxycurcumin) | Trials (bisdemethoxycurcumin) | Recent Studies (post-2010) (bisdemethoxycurcumin) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 238 | 11 | 162 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | bisdemethoxycurcumin (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.06 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 5.1 | |
| CPG DNA methylase | Spiroplasma monobiae | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assefa, H; Buolamwini, JK | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for caffeic acid phenethyl ester and bisdemethoxycurcumin
| Article | Year |
|---|---|
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Topics: Binding Sites; Cinnamates; HIV Integrase Inhibitors; HIV-1; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship | 2002 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |